13F filer · CIK 1388325
NOVO HOLDINGS A/S
HELLERUP, G7 · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$1.7B
+$488.0M vs prior
Positions
25
New / sold out
6 / 3
Added / reduced
2 / 8
Turnover
11.6%
buys $396.8M · sells $170.8M
Top-10 weight
73.5%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | HEMAB THERAPEUTICS HLDGS INC | +4,180,550 | – | +$153.6M |
| New | AVALYN PHARMACEUTICALS INC | +3,883,289 | – | +$127.8M |
| New | FLOOR & DECOR HLDGS INC | +797,000 | – | +$47.3M |
| New | ALUMIS INC | +1,100,000 | – | +$31.0M |
| New | DYNE THERAPEUTICS INC | +960,394 | – | +$21.3M |
| New | INSMED INC | +120,723 | – | +$12.9M |
| Added | VIRIDIAN THERAPEUTICS INC | +135,000 | +6.8% | +$2.5M |
| Added | BRIDGEBIO ONCOLOGY THERAPEUT | +64,077 | +2.9% | +$488.3K |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | APOGEE THERAPEUTICS INC | -450,000 | -100.0% | $-37.9M |
| Sold out | BIOMARIN PHARMACEUTICAL INC | -660,000 | -100.0% | $-37.3M |
| Reduced | MIRUM PHARMACEUTICALS INC | -200,000 | -15.1% | $-23.4M |
| Reduced | ARRIVENT BIOPHARMA INC | -442,142 | -22.8% | $-15.4M |
| Reduced | ENLIVEN THERAPEUTICS INC | -280,000 | -21.9% | $-14.2M |
| Reduced | PHARVARIS N V | -350,000 | -20.0% | $-12.1M |
| Reduced | CRINETICS PHARMACEUTICALS IN | -230,000 | -14.8% | $-8.6M |
| Sold out | VALNEVA SE | -1,057,421 | -100.0% | $-6.6M |
| Reduced | CELLDEX THERAPEUTICS INC NEW | -175,000 | -14.6% | $-6.5M |
| Reduced | 4D MOLECULAR THERAPEUTICS IN | -401,559 | -11.0% | $-5.3M |
1 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | EDGEWISE THERAPEUTICS INCCOM | 5,350,000 | $217.4M | 12.62% |
| 2 | ASML HOLDING N VN Y REGISTRY SHS | 94,946 | $188.9M | 10.97% |
| 3 | HEMAB THERAPEUTICS HLDGS INCCOM SHS | 4,180,550 | $153.6M | 8.92% |
| 4 | BROOKFIELD CORPCL A LTD VT SH | 3,496,245 | $149.5M | 8.68% |
| 5 | MAPLIGHT THERAPEUTICS INCCOM | 3,686,622 | $132.1M | 7.67% |
| 6 | MIRUM PHARMACEUTICALS INCCOM | 1,125,000 | $131.7M | 7.65% |
| 7 | AVALYN PHARMACEUTICALS INCCOM SHS | 3,883,289 | $127.8M | 7.42% |
| 8 | SALESFORCE INCCOM | 393,187 | $61.6M | 3.58% |
| 9 | ARRIVENT BIOPHARMA INCCOM | 1,500,000 | $52.1M | 3.03% |
| 10 | ENLIVEN THERAPEUTICS INCCOM | 1,000,000 | $50.8M | 2.95% |
15 more rows. Subscribe for $29/month to see every row, download the data and use the API.